Central Research Associates, LLC dba Flourish Research

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes2 trials
• Endometriosis1 trial
• Osteoarthritis1 trial

Phase

• Phase 23 trials
• Phase 31 trial

Status

• Recruiting2 trials
• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Biomea Fusion Inc.2 trials
• Doron Therapeutics Inc.1 trial
• Organon and Co1 trial

Running trials

• Recruiting

  Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

  NCT07502508· Phase 2· Biomea Fusion Inc.· Source

  Contact: Biomea Fusion Inc.

• Active, not recruiting

  Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets

  NCT07502495· Phase 2· Biomea Fusion Inc.· Source

• Recruiting

  A Study to Evaluate the Efficacy and Safey of PTP-001 (MOTYS™) in Knee Osteoarthritis Patients (MOTION-P)

  NCT07219771· Phase 3· Doron Therapeutics Inc.· Source

  Contact: Baleigh Baker

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Osteoarthritis1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Completed

  A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain

  NCT05560646· Phase 2· Organon and Co· Source